|
|
Volumn 26, Issue 5, 2000, Pages 293-297
|
|
Thromboembolic disease prophylaxis in patients with heart disease;Profilaxis de la enfermedad tromboembolica en enfermos con cardiopatia
a
|
|
Author keywords
Anticoagulants; Heart diseases; Platelet aggregation inhibitors; Thromboembolism prevention and control
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
DIPYRIDAMOLE;
TICLOPIDINE;
TRIFLUSAL;
SALICYLIC ACID DERIVATIVE;
ADULT;
AGE;
AGED;
ANTICOAGULANT THERAPY;
ARTICLE;
CARDIOVASCULAR RISK;
CLINICAL PROTOCOL;
DIABETES MELLITUS;
DYSLIPIDEMIA;
FEMALE;
HEART ATRIUM FIBRILLATION;
HEART DILATATION;
HEART DISEASE;
HUMAN;
HYPERTENSION;
ISCHEMIC HEART DISEASE;
MAJOR CLINICAL STUDY;
MALE;
RISK FACTOR;
SEX;
SMOKING;
THROMBOCYTE AGGREGATION INHIBITION;
THROMBOEMBOLISM;
VALVULAR HEART DISEASE;
COMPARATIVE STUDY;
CROSS-SECTIONAL STUDY;
MIDDLE AGED;
SEX DIFFERENCE;
AGE FACTORS;
AGED;
AGED, 80 AND OVER;
ANTICOAGULANTS;
ASPIRIN;
CROSS-SECTIONAL STUDIES;
DIPYRIDAMOLE;
FEMALE;
HEART DISEASES;
HUMANS;
MALE;
MIDDLE AGED;
PLATELET AGGREGATION INHIBITORS;
RISK FACTORS;
SALICYLATES;
SEX FACTORS;
THROMBOEMBOLISM;
TICLOPIDINE;
|
|
EID: 0033768561
PISSN: 02126567
EISSN: None
Source Type: Journal
DOI: 10.1016/s0212-6567(00)78667-7 Document Type: Article |
|
Times cited : (2)
|
|
References (21)
|
